Teresa Mato-Patino

Teresa Mato-Patino

Auto-generated profile, based on publicly available information

Teresa Mato-Patino

Department of Otolaryngology, La Paz University Hospital, Madrid, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
ISIsabel Sanchez-Cuadrado
Isabel Sanchez-Cuadrado
TMTeresa Mato-Patino
Teresa Mato-Patino
JMJOSE MANUEL MORALES-PUEBLA
JOSE MANUEL MORALES-PUEBLA
JPJulio Peñarrocha
Julio Peñarrocha
JDJesús Diez-Sebastian
Jesús Diez-Sebastian
LLLuis Lassaletta
Luis Lassaletta

3 August 2023 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
TMTeresa Mato-Patino
Teresa Mato-Patino
ISIsabel Sanchez-Cuadrado
Isabel Sanchez-Cuadrado
JPJulio Peñarrocha
Julio Peñarrocha
JMJOSE MANUEL MORALES-PUEBLA
JOSE MANUEL MORALES-PUEBLA
JDJesús Díez-Sebastián
Jesús Díez-Sebastián
LLLuis Lassaletta
Luis Lassaletta
Purpose: The clinician-graded electronic facial paralysis assessment (eFACE) is a relatively new digital tool for assessing facial palsy. The present study aimed to determine the validity and reliability of the Spanish version of the eFACE. Methods: Forward–backward translation from the original English version was performed. Videos and photographs from 65 adult patients with unilateral facial paralysis (any severity, time course, and etiology) were evaluated twice by five otolaryngologists with varying levels of experience in facial palsy evaluation. Internal consistency was measured using Cronbach’s α and the intra- and inter-rater reliability were measured using intraclass correlation coefficient. Concurrent validity was established by calculating Spearman’s rho correlation (ρ) between the eFACE and the House–Brackmann scale (H–B) and Pearson’s correlation (r) between the eFACE and the Sunnybrook Facial Grading System (SFGS). Results: The Spanish version of the eFACE showed good internal consistency (Cronbach’s α > 0.8). The intra-rater reliability was nearly perfect for the total score (intraclass correlation coefficient: 0.95–0.99), static score (0.92–0.96), and dynamic score (0.96–0.99) and important-to-excellent for synkinesis score (0.79–0.96). The inter-rater reliability was excellent for the total score (0.85–0.93), static score (0.80–0.90), and dynamic score (0.90–0.95) and moderate-to-important for the synkinesis score (0.55–0.78). The eFACE had a very strong correlation with the H–B (ρ = – 0.88 and – 0.85 for each evaluation, p < 0.001) and the SFGS (r = 0.92 and 0.91 each evaluation, p < 0.001). Conclusion: The Spanish version of the eFACE is a reliable and valid instrument for assessment of facial function in the diagnosis and treatment of patients with facial paralysis.

1 February 2024 in The Journal of International Advanced Otology
Verified
Journal Article
Open access
LLLuis Lassaletta
Luis Lassaletta
ISIsabel Sanchez-Cuadrado
Isabel Sanchez-Cuadrado
TPTeresa Mato Patino
Teresa Mato Patino
JPJulio Peñarrocha
Julio Peñarrocha
MNMaría Angélica Rivera Núñez
María Angélica Rivera Núñez
JMJOSE MANUEL MORALES-PUEBLA
JOSE MANUEL MORALES-PUEBLA
BACKGROUND: Objectives: (1) To determine whether the incidence of Bell’s Palsy (BP) increased during the pandemic. (2) To investigate whether the outcomes of patients with BP and COVID-19 infection or vaccination differ from those in the pre-pandemic era. METHODS: Patients with BP were studied in 2 periods retrospectively (March 2021–March 2022 and August 2018–August 2019). A prospective study from March 2021 to March 2022 was also performed. Primary outcome was grade ≤Ⅱ in the House–Brackmann (HB) and/or >70 in the Sunnybrook facial grading system (SFGS) scales at the 12-week visit. Reverse transcriptase polymerase chain reaction (PCR) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and enzyme-linked immunosorbent assay-based SARS-CoV-2 immuonoglobulin G (IgG) test (blood) were measured. RESULTS: About 162 and 196 patients with BP were identified between March 2021 and March 2022 and August 2018 and August 2019, respectively. Forty-seven patients (29%) entered the prospective study; 85% had HB grades I or II, while 92% had an SFGS score of 71-100 at the last visit. Only 3 patients (6.5%) had a positive PCR during the initial episode, whereas 35 patients (77%) had positive IgG SARS-CoV-2. There was no association between positive PCR and facial function outcomes. Of the 162 patients, 105 (67%) had received COVID-19 vaccine. In 23 of them (22%), the paralysis appeared within the first 30 days after a vaccine dose. CONCLUSION: Coronavirus disease 2019 did not increase the incidence of BP. A direct association between the coronavirus and BP outcome cannot be established. The considerable number of patients developing BP within the first month suggests a possible association between COVID-19 vaccines and BP Cite this article as: Lassaletta L, Sanchez-Cuadrado I, Mato-Patino T, et al. Has coronavirus disease 2019 changed the incidence and outcome of bell’s palsy? J Int Adv Otol. 2024;20(1):19-25.

28 August 2025 in Facial Plastic Surgery & Aesthetic Medicine
Verified
Journal Article
Closed access
TMTeresa Mato-Patino
Teresa Mato-Patino
JMJosé Manuel Morales-Puebla
José Manuel Morales-Puebla
ISIsabel Sánchez-Cuadrado
Isabel Sánchez-Cuadrado
JTJulio Peñarrocha Terés
Julio Peñarrocha Terés
JSJosé Suazo
José Suazo
LLLuis Lassaletta
Luis Lassaletta
Introduction: Side-to-end hypoglossal–facial nerve transfer (HFT) is an established facial reanimation technique. However, evidence regarding predictors of outcomes is limited. Objective: To evaluate predictors of facial and tongue outcomes after HFT in a large series of patients with facial palsy. Methods: A retrospective review of 64 patients undergoing side-to-end HFT was conducted. Additional masseteric nerve transfer and/or cross-facial nerve grafting were performed in selected cases. Facial outcomes were evaluated with the House–Brackmann (HB) scale, the Sunnybrook Facial Grading System, and eFACE. Tongue outcomes were assessed using Martin’s scale and Oral and Pharyngeal Disability Index. Multivariate regression analyses identified independent associations. Results: HB grade III or IV was achieved in 95.3% of patients. Significant improvements were observed in all facial function scales ( p < 0.001). Tongue function was preserved in 98.4%. Patient-reported scores indicated good perceived oral–pharyngeal outcomes (79.3, interquartile range = 67.9–87.4). Higher age predicted poorer facial (β = −0.303, p = 0.009) and tongue (β = −0.371, p = 0.006) outcomes. Delayed recovery onset correlated with worse facial results (β = −0.389, p = 0.001). Double nerve reinnervation was associated with better facial outcomes ( p = 0.007). Conclusions: This technique offers effective facial reanimation with minimal tongue morbidity. Older age and delayed recovery onset were associated with poorer outcomes, supporting tailored surgical strategies.